A Developmental Perspective to Attention-Deficit Hyperactivity Disorder (ADHD) in Children


  • Emmanuel Afolabi Olusegun University of Botswana, Botswana




attention deficit hyperactive disorder, developmental perspectives, childhood disorder, genetic factors, environmental factors.


The debate about diagnoses and treatment of attention deficit hyperactive disorder (ADHD) in children continue to range on between the developmental and biological perspectives. While there is increasing evidence that support the biological susceptibility of the disorder, a number of researches also emphasized the significant effect of environment on the syndrome. This study used developmental perspectives to evaluate and bring together various bio-psychosocial factors that impact on children diagnosed with ADHD. The study explored and integrated the existing and advancing study on ADHD to a more refined pattern that embraced developmental perspectives. The study also discussed how the linkage in childhood ADHD fits within the developmental psychopathology perspective. The study revealed that ADHD as a developmental disorder is influenced by prenatal, biological and psychosocial environmental risk factors, and suggested that better understanding of genomic susceptibilities, family environment and parental characteristics would transform the pathway for development of ADHD in children.


  • American Psychiatric Association.(2000). Diagnostic and StatisticalManual of Mental
    Disorders. 4th ed. Washington, DC: American Psychiatric Association.
  • American Psychiatric Association.(2013). Diagnostic and StatisticalManual of Mental
    Disorders.5th ed. Washington, DC: American Psychiatric Association.
  • Arnsten, A.F, (2007). Catecholamine and second messenger influenceson prefrontal
    cortical networks of “representational knowledge”:a rational bridge between genetics and
    the symptoms of mental illness. Cerebral Cortex, 17, i6–i15.
  • Arnsten, A.F, & Pliszka, S.R. (2011). Catecholamine influences on prefrontalcortical
    function: relevance to treatment of attentiondeficit/hyperactivity disorder and related
    disorders. Pharmacology, Biochemistry and Behavior, 99, 211–216.
  • Atladóttir H.O, Parner E.T, & Schendel D. (2007). Variation in incidence of
    neurodevelopmental disorders with season of birth. Epidemiology, 18, 240–245.
  • Barkley, R. A. (2006). Attention deficit/hyperactivity disorder: A handbook for diagnosis
    and treatment (3rd ed.). New York: Guilford
  • Baumeister A.A, Hawkins M.F (2001). Incoherence of neuroimaging studies of attention
    deficit/ hyperactivity disorder. Clinical Neuropharmacology, 24, 2–10.
  • Berger I. (2011). Diagnosis of attention deficit hyperactivity disorder: much ado about
    something. Israeli Medical Association Journal, 13, 571–574.
  • Berger, A., Posner, M. I. (2000). Pathologies of brain attentionalnetworks. Neuroscience
    and Biobehavioral Reviews, 24, 3–5.
  • Biederman J, Faraone S.V, Keenan K, Knee D, &Tsuang M.T (1990): Familygenetic and
    psychosocial risk factors in DSM-III attention deficit disorder. Journal of American
    Academy of Child and Adolescent Psychiatry, 29, 526 –533.
  • Biederman J, Faraone SV, Keenan K, Tsuang MT (1991b): Evidence of familialassociation
    between attention deficit disorder and major affective disorders. Archives of General
    Psychiatry, 48, 633–642.
  • Biederman, J, Faraone, S.V, Keenan K, Benjamin, J, Krifcher, B. &Moore C. et al (1992).
    Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder.
    Patterns of comorbidity in probands and relativesin psychiatrically and pediatrically
    referred samples. Archives of General Psychiatry, 49, 728 –738.
  • Biederman, J., Milberger, S., Faraone, S. V., Kiely, K., Guite, J.,Mick, E., Ablon, S.,
  • Warburton, R., & Reed, E. (1995). Family environment risk factors for attention deficit
    hyperactivity disorder: A test of Rutter’s indicators of adversity. Archives of General
    Psychiatry, 52, 464–470.
  • Biederman, J., Faraone, S.V., Mick, E., Spencer,T.,Wilens,T., Kiely,K., Guite, J., Ablon, J.
    S., Reed, E., & Warburton, R. (1995). High risk for attention deficit hyperactivity disorder
    among children of parents with childhood onset of the disorder: A pilot study. Journal of
    American Psychiatry, 152, 431–435.
  • Biederman J, Faraone S.V, Monuteaux M, Spencer T, Wilens T, Bober M, et al (2004).
    Gender effects of attention deficit hyperactivity disorder inadults, revisited. Biological
    Psychiatry, 55, 692–700.
  • Brookes, K.,Mill, J.,&Guindalini,C., et al (2006). Acommon haplotype of the dopamine
    transporter geneassociated with attention-deficit/hyperactivity disorderand interacting
    withmaternal use of alcohol duringpregnancy. Archives of General Psychiatry, 63, 74–81.
  • Brophy, K., Hawi, Z., Kirley, A., Fitzgerald, M., & Gill, M. (2002). Synaptosomalassociated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD):
    Evidence of linkage and association in the Irish population. Molecular Psychiatry, 7 , 913–
  • Campbell, S. B. (2000). Attention-Deficit/Hyperactivity Disorder: A developmental view.
    In: Handbook of Developmental Psychopathology. (pp. 383–401). A. J. Sameroff, M.
    Lewis, & S. Miller (Eds.). New York: Kluwer Academic/Plenum.
  • Carlson, E. A., Jacobvitz, D., & Sroufe, L. A. (1995). A developmental investigation of
    inattentiveness and hyperactivity. Child Development, 66, 37–54.
  • Childress, A.C, Berry, S.A (2012). Pharmacotherapy of attention-deficit hyperactivity
    disorder in adolescents. Drugs, 72, 309–325.
  • Cortese, S (2012). The neurobiology and genetics of attention-deficit/hyperactivity
    disorder (ADHD): what every clinician shouldknow. European Journal of Paediatric
    Neurology, 16, 422–433.
  • Dopheide, J.A (2005). ASHP therapeutic position statement on theappropriate use of
    medications in the treatment of attention deficit/hyperactivity disorder in paediatric
    patients. American Journal of Health System Pharmacy, 62, 1502– 1509.
  • Coghill, D., Nigg, J., Rothenberger, A., Sonuga-Barke, E., & Tannock, R. (2005). Wither
    causal models in the neuroscience of ADHD? Developmental Science, 8, 105–114.
  • Cummings, E. M., Davies, P., & Campbell, S. B. (2000). Developmental Psychopathology
    and Family Process: Research, Theory, and Clinical Implications. New York: Guilford.
  • Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M.
    A., et al. (2005). Molecular genetics of attention-defi cit/hyperactivity disorder. Biological
    Psychiatry, 57 , 1313–1323.
  • Faraone, S, Biederman, J, Krifcher Lehman, B, Keenan, K, Norman, D, Seidman, L. et al.
    (1993). Evidence for the independent familial transmission of attentiondeficit hyperactivity
    disorder and learning disabilities: Results froma family genetic study. American Journal
    of Psychiatry, 150, 891– 895.
  • Faraone, S. V, Tsuang, M. T. (1995). Methods in psychiatric genetics. In: Textbook in
    Psychiatric Epidemiology, Tohen, M, Tsuang, M., Zahner, G. (Eds). (pp. 81–134). New
    York: John Wiley& Sons.
  • Faraone, S. V. & Biederman, J. (1998). Neurobiology of attentiondeficit hyperactivity
    disorder. Biological Psychiatry, 44, 951–958.
  • Faraone S.V, Biederman J, &MonuteauxM.C. (2001a). Attention deficit hyperactivity
    disorder with bipolar disorder in girls: Further evidence for a familial subtype? Journal of
    Affect Disorders, 64, 19 –26.
  • Haraone S.V, Doyle A.E (2001): The nature and heritability of attentiondeficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America,
    10, 299 –316, viii–ix.
  • Faraone, S.V., & Biederman, J. (2000). Nature, nuture, and attentiondeficit hyperactivity
    disorder. Developmental Review, 20, 568–581.
  • Faraone S.V, Perlis R.H, Doyle A.E, Smoller J.W, Goralnick J, &Holmgren M.A, et al.
    (2005). Molecular genetics of attention deficit hyperactivity disorder. Biological
    Psychiatry, 57, 1313–1323.
  • Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991) The
    neuropsychology of schizophrenia. Behavioral and Brain Sciences, 14, 1–84.
  • Gray, J. A. (1982). The neumpsychology of anxiety. New York: Oxford University Press.
  • Halperin, J. M., & Healey, D. M. (2011). The infl uences of environmental enrichment,
    cognitive enhancement,and physical exercise on brain development: Can we alter the
    developmental trajectory of ADHD? Neuroscience and Biobehavioral Reviews, 35 , 621–
  • Hauschild K.M, Mouridsen S.E, & Nielsen S. (2005). Season of birth inDanish children
    with language disorder born in the 1958–1976 period. Neuropsychobiology; 51, 93–99.
  • Hudziak J.J, Rudiger L.P, Neale M.C, Heath A.C, & Todd R.D (2000). A twin study of
    inattentive,aggressive, and anxious/depressed behaviors. Journal of the American Academy
    of Child and Adolescent Psychiatry, 39, 469 –476.
  • Kahn, R. S., Khoury, J. & Nichols,W.C., et al (2003). Role of dopamine transporter
    genotype and maternal prenatal smoking in childhood hyperactive-impulsive,inattentive,
    and oppositional behaviors. Journal of Pediatrics, 143, 104–110.
  • Kesner R.P, & Churchwell J.C (2011). An analysis of rat prefrontal cortexin mediating
    executive function. Neurobiology of Learning and Memory, 96, 417–431.
  • Kuntsi, J.,& Stevenson, J. (2000). Hyperactivity in children:Afocuson genetic research and
    psychological theories. Clinical Child and Family Psychology Review, 3, 1–24.
  • Langley, K., Rice, F., & van den Bree, M. B., et al (2005). Maternal smoking during
    pregnancy as an environmental risk factor for attention deficit hyperactivity disorder
    behaviour. A Review. Minerva Pediatrica, 57, 359–371.
  • Manshadi M, Lippmann S, O’Daniel R, & Blackman A (1983): Alcohol abuse and
    attention deficit disorder. Journal of Clinical Psychiatry, 44, 379 –380
  • Martin N, Scourfield J, McGuffin P (2002).Observer effects and heritability ofchildhood
    attention-deficit hyperactivity disorder symptoms. British Journal of Psychiatry, 80, 260 –
  • Neale, B. M., Medland, S. E., Ripke, S., Asherson, P., Franke, B., Lesch, K. P., et al.
    (2010). Meta-analysis of genome-wide association studies of attention-defi cit/
    hyperactivity disorder. Journal of the American Academy of Child and Adolescent
    Psychiatry, 49 , 884–897.
  • Nigg J, Nikolas M, & Burt S. A(2010). Measured gene-by-environment interaction in
    relation to attention-deficit/hyperactivity disorder. Journal of the American Academy of
    Child and Adolescent Psychiatry, 49, 863–73.
  • Oades, R. D., Lasky-Su, J., Christiansen, H., Faraone, S.V., Sonuga-Barke, E. J.,
  • Banaschewski, T., et al. (2008). The influence of serotonin- and other genes onimpulsive
    behavioral aggression and cognitive impulsivity in children with attentiondeficit/hyperactivity. A Developmental Perspective on ADHD disorder (ADHD): Findings
    from a family-based association test (FBAT) analysis. Behavioral and Brain Functions, 4,
  • Pastor P. N & Reuben C.A. (2008). Diagnosed attention deficit hyperactivity disorder and
    learning disability: United States, 2004–2006. Vital Health Statistics, 10, 1–14.
  • Quay, H. C. (1988a). Attention deficit disorder and the behavioral inhibitionsystem: The
    relvance of the neuropsychological theory of Jeffrey A. Gray. In: Attention deficit
    disorder: Criteria, cognition, intervention (pp. 117–126). L. M. Bloomingdale & J.
    Sergeant (Eds.). NewYork: Pergamon.
  • Quay, H. C. (1988b). The behavioral reward and inhibition systems inchildhood behavior
    disorder. In: Attentiondeficit disorder W; New research in treatment, psychopharnmcology,
    and attention (pp. 176–186). L. M. Bloomingdale (Ed.). NA: Pergamon.
  • Quay, H. C. (1996, January). Gray'sbehavioral inhibition in ADHD:An update. Paper
    presented at the annual meeting of the InternationalSociety for Research in Child and
    Adolescent Psychopathology, Los Angeles, CA.
  • Rader, R, McCauley L,& Callen, E.C. (2009). Current strategies in thediagnosis and
    treatment of childhood attention-deficit/hyperactivity disorder. American Family
    Physician, 79, 657–665.
  • Robbins, T. W. (2003). Dopamine and cognition. Currpin Neurol,16, (2), S1–S2.
  • Rutter, M, Cox, A, Tupling, C, Berger, M, &Yule, W. (1975). Attainment and adjustment
    in two geographical areas. 1—The prevalence of psychiatric disorders. British Journal of
    Psychiatry, 126, 493–509.
  • Rutter, M., &Sroufe, L. A. (2000). Developmental psychopathology: Concepts and
    challenges. Development and Psychopathology, 12, 265–296.
  • Sergeant, J. (2000). The cognitive-energetic model: An empiricalapproach to attentiondeficit hyperactivity disorder. Neuroscienceand Biobehavioral Reviews, 24, 7–12.
  • Sherman D, McGue M, &Iacono W (1997). Twin concordance for attention deficit
    hyperactivity disorder: A comparison of teachers’ and mothers’reports. American Journal
    of Psychiatry, 154, 532–535.
  • Sonuga-Barke, E. J., Auerbach, J., Campbell, S. B., Daley, D., & Thompson, M. (2005).
    Preschool varieties of hyperactive and dysregulated behaviour: Multiple pathways between
    risk and disorder. Developmental Science, 8 , 141–150.
  • Sonuga-Barke, E. J., Bitsakou, P., & Thompson, M. (2010). Beyond the dual pathway
    model: Evidence for the dissociation of timing, inhibitory, and delayrelated impairments in
    attention-defi cit/hyperactivity disorder. Journal of the American Academy of Child and
    Adolescent Psychiatry, 49 , 345–355.
  • Sonuga-Barke, E. J., & Halperin, J. (2010). Developmental phenotypes and causal
    pathways in attention deficit/hyperactivity disorder: Potential targets for early
    intervention? Journal of Child Psychology and Psychiatry, 51, 368–398.
  • Sprich-Buckminster S, Biederman J, Milberger S, Faraone S, &Krifcher LehmanB (1993):
    Are perinatal complications relevant to the manifestation ofADD? Issues of comorbidity
    and familiality. Journal of American Academy of Child and Adolescent Psychiatry,32,
  • Swanson, J. M., Sunohara, G. A., Kennedy, J. L., Regino,R., Fineberg, E.,Wigal, T.,
    Lerner, M.,Williams, L., LaHoste,G. J.,&Wigal, S. (1998). Association of the dopamine
    receptorD4 (DRD4) gene with a refined phenotype of attention deficithyperactivity
    disorder (ADHD): A family–based approach.Molecular Psychiatry, 3, 38–41.
  • Taylor, E. (1999). Developmental neuropsychopathology of attentiondeficit and impulsiveness. Development and Psychopathology, 11, 607–628.
  • Thapar, A.,O’Donovan,M., &Owen,M. J. (2005b). The genetics of attention deficit
    hyperactivity disorder. Human Molecular Genetics, 14, 275–282.
  • Thapar, A., Langley, K.,O’Donovan,M. (2006). Refining the attention deficit
    hyperactivity disorderphenotype formolecular genetic studies. Molecular Psychiatry, 11,
  • Thapar A, Langley K, &Asherson P, (2007). Gene–environment interplay in attentiondeficit hyperactivity disorder and the importance of a developmental perspective. British
    Journal of Psychiatry 190, 1–3.
  • Tochigi M, Okazaki Y, & Kato N, (2004). What causes seasonality of birth in
    schizophrenia? Neuroscience Res, 48, 1–11
  • Trent S & Davies W. (2012). The influence of sex-linked genetic mechanisms on attention
    and impulsivity. Biological Psychology, 89, 1–13.
  • United States, 2003 and 2007 (2010). Increasing prevalence of parent-reported attentiondeficit/hyperactivity disorder among children, MMWR Morb Mortal Wekly Rep, 59, 1439–
  • Yehuda, R. (2000). Biology of posttraumatic stress disorder. Journal of Clinical
    Psychiatry, 61, 14–21.
  • Zimmer, L (2009). Positron emission tomography neuroimagingfor a better understanding
    of the biology of ADHD. Neuropharmacology, 57, 601–607.



Download data is not yet available.

Author Biography

Emmanuel Afolabi Olusegun , University of Botswana, Botswana




How to Cite

Emmanuel Afolabi Olusegun. (2016). A Developmental Perspective to Attention-Deficit Hyperactivity Disorder (ADHD) in Children. East European Journal of Psycholinguistics, 3(1), 8–22. https://doi.org/10.29038/eejpl.2016.3.1.olu



Vol 3 No 1 (2016)